ES266270A1 - Procedimiento para preparar vacunas poliomieliticas - Google Patents

Procedimiento para preparar vacunas poliomieliticas

Info

Publication number
ES266270A1
ES266270A1 ES0266270A ES266270A ES266270A1 ES 266270 A1 ES266270 A1 ES 266270A1 ES 0266270 A ES0266270 A ES 0266270A ES 266270 A ES266270 A ES 266270A ES 266270 A1 ES266270 A1 ES 266270A1
Authority
ES
Spain
Prior art keywords
vaccines
polyomyelitic
preparing
procedure
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0266270A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES266270A1 publication Critical patent/ES266270A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32651—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES0266270A 1960-03-30 1961-03-22 Procedimiento para preparar vacunas poliomieliticas Expired ES266270A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18500A US3097142A (en) 1960-03-30 1960-03-30 Benzyl alcohol stabilized polio vaccines and production thereof

Publications (1)

Publication Number Publication Date
ES266270A1 true ES266270A1 (es) 1961-07-01

Family

ID=21788244

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0266270A Expired ES266270A1 (es) 1960-03-30 1961-03-22 Procedimiento para preparar vacunas poliomieliticas

Country Status (5)

Country Link
US (1) US3097142A (es)
BE (1) BE601851A (es)
ES (1) ES266270A1 (es)
FR (1) FR1265M (es)
GB (1) GB949400A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1154900B (de) * 1961-10-10 1963-09-26 Behringwerke Ag Verfahren zur Herstellung einer Poliomyelitisvaccine
CA2065023A1 (en) * 1989-08-15 1991-02-16 Brent Dorval Stabilized vaccine compositions
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR885966A (fr) * 1941-10-07 1943-09-30 Ig Farbenindustrie Ag Agents désinfectants
US2793160A (en) * 1955-05-09 1957-05-21 Parke Davis & Co Poliomyelitis vaccine

Also Published As

Publication number Publication date
BE601851A (fr) 1961-09-27
FR1265M (fr) 1962-06-24
GB949400A (en) 1964-02-12
US3097142A (en) 1963-07-09

Similar Documents

Publication Publication Date Title
GB960850A (en) Measles virus vaccine
GB949400A (en) Poliomyelitis vaccines
ES446637A1 (es) Procedimiento para la preparacion de vacunas acelulares.
ES394117A1 (es) Procedimiento de preparacion de principios medicinales ac- tivos.
ES266340A1 (es) Procedimiento para la preparaciën de vacunas poliemieliticas
CH238143A (de) Verfahren zur Herstellung von 4,4'-Dibrom- ,ss-dimethyl-stilben.
GB958564A (en) Vaccines containing clostridium perfringens ª‰-toxoid
GB560694A (en) Improvements in insecticides
CA607992A (en) Stable poliomyelitis live virus vaccine
ZA795459B (en) Use of n,n-dimethyl-n'-p-tolyl-n'-dichloro-fluoromethylthio-sulphamide for combating fungi which damage wood
NL155263B (nl) Werkwijze ter bereiding van fosfor-, fosfon-, thionofosfor- en/of thionofosfonzuuresters met insekticide en akaricide werking.
FR11M (fr) Chlorhydrate de l'éther β-diéthylaminoéthylique de l'alcool dibromo-3,5 méthoxy-2 benzylique.
ES287531A1 (es) Procedimiento para la preparacion de una composicion insecticida o larvicida para usar contra los mosquitos
GR17790B (el) Μεθοδος δια την παρασκευην αλατων πενικιλλινων σταθερων εναντι οξεων.
ES224455A1 (es) PROCEDIMIENTO DE PREPARACIoN DE VACUNAS DE TROPISMO TISULAR
ES255146A3 (es) Metodo de preparaciën de antigenos inmunizadores eficaces en la vacunaciën de ganado vacuno
ES271671A1 (es) Procedimiento de preparaciën de fungicidas
IE22524L (en) Poliomyelitis virus vaccine
DK105029C (da) Fremgangsmåde til fremstilling af 1-[5',6',7',8'-tetrahydronaphthyl-(1')-amino]-imidazolin eller syreadditionssalte heraf.
DK116282B (da) Fremgangsmåde til fremstilling af N-substituerede 2,3-polymethylenindoler eller syreadditionssalte deraf.
DK76415C (da) Fremgangsmåde til fremstilling af i 17-stilling substituerede, mættede eller umættede androstan-17-ol-3-oner og deres enolater eller acetaler.
FI40401C (fi) Menetelmä kestävien, suun kautta nautittavien poliomyelitisvirus-preparaattien valmistamiseksi
ES251770A1 (es) Procedimiento para la obtenciën de agentes para la conservaciën
FR1636M (fr) Composition bihormonale injectable, utile notamment comme médicament anti-abortif.
ES321833A1 (es) Procedimiento para la obtencion de una vacuna contra el moquillo